Hzymes, a leading innovator in enzyme technology for clinical and diagnostic applications, is proud to announce its participation in ESCMID Global 2025, the Annual Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). The event will be held from April 11 to April 15, 2025, at Reed Messe Wien GmbH in Vienna, Austria. Hzymes will be exhibiting at Booth No. I22.

About ESCMID Global 2025
ESCMID Global is Europe’s premier international conference for professionals in clinical microbiology and infectious diseases. With more than 12,000 core members and over 45,000 affiliated professionals from 77 national and international societies, the event is a key platform for networking, knowledge-sharing, and showcasing groundbreaking research in the fight against infectious diseases and antimicrobial resistance.

Founded in 1983, ESCMID continues to lead in promoting global collaboration, research innovation, and education in the fields of infectious diseases and microbiology—playing a critical role especially in the post-COVID-19 era.

Hzymes at ESCMID: Driving Innovation in Infectious Disease Diagnostics
At ESCMID Global 2025, Hzymes will spotlight its latest enzyme-based solutions tailored for molecular diagnostics, pathogen detection, and antimicrobial resistance research. Visitors to Booth I22 can explore Hzymes’ advanced product portfolio designed to meet the evolving needs of clinical laboratories and healthcare providers.

As a biotechnology company committed to enhancing diagnostic accuracy and speed, Hzymes is excited to engage with researchers, clinicians, and industry leaders at ESCMID. The event provides an excellent opportunity for collaboration, technology exchange, and insight into emerging global health challenges.

Why Visit Hzymes at ESCMID Global 2025?
Discover innovative enzymes for use in infectious disease diagnostics
Learn how Hzymes supports faster and more accurate detection of pathogens
Connect with Hzymes’ scientific and business development teams
Explore partnership opportunities in R&D and clinical applications

Recommended Products: